Else Nutrition signs distribution agreement with Walmart.com
Else Toddler Nutrition will be available in the online store of the nation’s largest grocery retailer by Q4 2021
VANCOUVER, British Columbia, August 12, 2021 (GLOBE NEWSWIRE) – ELSE NUTRITION HOLDINGS INC. (BABY V) (BABYF) (0YL.F) (“Other” or the “Company”) the plant-based nutrition company for babies, toddlers and children, announces that it has signed an online distribution agreement with Walmart.com and will expand into Walmart’s e-commerce marketplace (Walmart. com) by the fourth quarter of 2021 with its comprehensive offering of herbal nutrition products for toddlers.
“Joining Walmart.com is a very important step for the company,” said Hamutal Yitzhak, CEO and co-founder of Else Nutrition. “The sheer size of Walmart.com will allow us to reach thousands of new families and grow significantly over the next 3 years,” she added.
According to eMarketer, Walmart’s e-commerce sales in the United States before the pandemic were $ 30 billion and are expected to reach more than $ 64 billion by the end of 2021.
Walmart.com traffic was much higher last year than pre-pandemic levels. Online shopping, particularly in the grocery and Fast Moving Consumer Goods segment, has seen a resurgence in popularity due to the pandemic. Walmart was the largest grocery retailer in the United States in 2019, with 65% of Walmart’s US $ 510.329 billion sales coming from US operations.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean, plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary plant-based, soy-free formula is an alternative to the unique ingredient in the dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked # 1 for selling in the Baby & Toddler Formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed on the TSX Venture Exchange under the symbol BABY and is listed on the US OTC Markets QX under the symbol BABYF and on the Frankfurt Stock Exchange under the symbol 0YL. Else executives include executives from leading infant nutrition companies. Many of Else’s advisory board members have held senior positions in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition companies, and some of them currently hold various positions in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam and Technion Medical Center, Israel and Hospital University of Brussels, Belgium.
For more information visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
Brilliant public relations
For more information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder and Director
ELSE Nutrition Holdings Inc.
E: [email protected]
Phone. : +972 (0) 3-6445095
Mr. Sokhie Puar, Director of Else Nutrition
E: [email protected]
Phone. : 604-603-7787
Contact for U.S. Investor Relations
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
E: [email protected]
Phone. : 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are generally identified by words such as “will” or similar expressions. The forward-looking statements contained in this press release include statements regarding the expected filing dates of the Company’s financial information documents. These forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors that management considers appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements in this press release assume, among other things, that there will be no supply chain disruptions or failures due to COVID 19 and that the agreement to manufacture, broker and supply logistics with the Company will not end. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.